SARS-CoV-2-specific T-cell responses after COVID-19 recovery in patients with rheumatic diseases on immunosuppressive therapy

BACKGROUND: In patients with immune-mediated rheumatic diseases (RMD), the development of T-cell responses against SARS-CoV-2 may be impaired by either the immune disturbances associated with the disease, or by the effects of immunosuppressive therapies. We aimed at determining the magnitude of SARS...

Descripción completa

Detalles Bibliográficos
Autores principales: Lledó, Ana, Retuerto, Miriam, Almendro-Vázquez, Patricia, Fernández-Ruiz, Mario, Galindo, María, Laguna-Goya, Rocío, Paz-Artal, Estela, Lalueza, Antonio, Aguado, José M., Pablos, José L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572149/
https://www.ncbi.nlm.nih.gov/pubmed/34775160
http://dx.doi.org/10.1016/j.semarthrit.2021.10.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572149/
https://www.ncbi.nlm.nih.gov/pubmed/34775160
http://dx.doi.org/10.1016/j.semarthrit.2021.10.006

Ejemplares similares